¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú The 2nd Precision Oncology International Symposium (The SMC – Gustave Roussy Partnership : Research Cures Cancer) : 2024-02-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

»ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú The 2nd Precision Oncology International Symposium (The SMC – Gustave Roussy Partnership : Research Cures Cancer) : 2024-02-02
±³À°ÀÏÀÚ : 2024-02-02
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1Ãþ °­´ç

±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁ º´Çà)The 2nd Precision Oncology International Symposium (The SMC – Gustave Roussy Partnership : Research Cures Cancer)

ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷¾×Á¾¾ç³»°ú

´ã´çÀÚ : ³ëÀÎÈñ
¿¬¶ôó : 02-2148-9826

À̸ÞÀÏ : lipm.smc@samsung.com

±³À°Á¾·ù : ³»°ú, ÀÇ»çÇÐ

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 70,000¿ø  

ºñ°í »çÀüµî·Ï: ¨çÀü¹®ÀÇ 50,000¿ø ¨èÀü°øÀÇ 30,000¿ø ¨é±âŸ 10,000¿ø´çÀϵî·Ï: ¨çÀü¹®ÀÇ 70,000¿ø ¨èÀü°øÀÇ 50,000¿ø ¨é±âŸ 30,000¿ø (¿ÀÇÁ¶óÀÎ ÁøÇà ½Ã, ¡°ÇöÀåµî·Ï¡±)KMA È®ÀÎ¿ë ¾ÆÀ̵ð 0000(¼ýÀÚ) ºñ¹Ð¹øÈ£ 0000(¼ýÀÚ)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 08:50~08:55 Welcome Messages from SMC leadership ¹Ú½Â¿ì(»ï¼º¼­¿ïº´¿ø)

±âŸ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 08:55~09:00 The Partnership between SMC & Gustave Roussy Fabrice BarlesiÀÌ¿ì¿ë(Gustave Roussy»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 09:00~09:20 Gustave Roussy: an overview to cure cancer as an institution Fabrice Barlesi(Gustave Roussy)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 09:20~09:45 Functional precision medicine in GI cancers Alice Boileve(Gustave Roussy)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 09:45~10:05 Drug development from academia to clinical trials ³²µµÇö(»ï¼º¼­¿ïº´¿ø ½Å°æ¿Ü°ú)

Åä·Ð 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 10:05~10:15 Q&A ( )

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 10:15~10:30 Precision Cancer Medicine at SMC ÀÌÁö¿¬(»ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 10:30~10:45 Adoptive T cell therapy for refractory cancer patients: from concept to clinical trials ±è½ÂÅÂ(»ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 10:45~11:00 AI driven drug discovery from bed to benchside ¼­¼º¿í(»ï¼º¼­¿ïº´¿ø Á¤Çü¿Ü°ú)

Åä·Ð 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 11:00~11:10 Q&A ( )

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 11:10~11:35 Gustave Roussy : Translational projects in immunoradiotherapy Eric Deutsch(University of Paris-Saclay)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 11:35~11:50 Deep learning-based auto-segmentation of target volume ³ëÀç¸í(»ï¼º¼­¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 11:50~12:05 Experience in clinical trials combining Immunotherapy and radiotherapy ¹ÚÈñö(»ï¼º¼­¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

½Ä»ç 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 12:05~13:00 Á¡½É ( )

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 13:00~13:25 From concept to implementation : 15 years of precision medicine program of Gustave Roussy Fabrice André(Gustave Roussy)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 13:25~13:50 Precision medicine is finally becoming the reality in prostate cancer Karim Fizazi(Gustave Roussy)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 13:50~14:05 Insights from healthcare big data for sustainable, long-term cancer control È«Á¤¿ë(»ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 14:05~14:20 S​patiotemporally Resolved Single-cell Analyses Delineate Early Esophageal Squamous Carcinogenesis ¹Îº´ÈÆ(»ï¼º¼­¿ïº´¿ø ¼ÒÈ­±â³»°úºÐ°ú)

ÈÞ½Ä 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 14:20~14:40 Q&A / Coffee Break ( )

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 14:40~14:55 Application of 3D Printing-Assisted Tumor Microenvironment in Translational Oncology Çü¼öÁø(»ï¼º¼­¿ïº´¿ø Á¤¹ÐÀÇÇÐÇõ½Å¿¬±¸¼Ò)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 14:55~15:10 Innovations in liver surgery and the potential role of surgeons on precision medicine À¯Áø¼ö(»ï¼º¼­¿ïº´¿ø À̽ĿܰúºÐ°ú)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 15:10~15:25 Therapeutic targeting of the tumor microenvironment in colorectal cancer Á¶¿ë¹ü(»ï¼º¼­¿ïº´¿ø ´ëÀåÇ×¹®¿Ü°úºÐ°ú)

±³À°½Ã°£ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 15:25~15:35 Dynamics of tumor specific-T cells in diverse immune landscape in advanced gastric cancer. ¾È¹Î¾Ö(»ï¼º¼­¿ïº´¿ø Çõ½Å¹Ì·¡ÀǷῬ±¸¼¾ÅÍ)

Åä·Ð 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 15:35~15:45 Panel discussion for Collaborative Work ( )

±âŸ 02¿ù 02ÀÏ »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ °­´ç 15:45~15:50 Closing Remark ÀÌ¿ì¿ë( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø 2024 CMC Spine Symposium: Better care for spine : 2024-02-02
´ÙÀ½±Û ´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À° : 2024-01-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20559 °æ±â Á¦34Â÷ Áß¾Ó´ëÇб³ ºñ´¢ÀÇÇаú ¿öÅ©¼¥ : 2024-06-01 0 61 2024-04-29
20558 ±¤ÁÖ Á¦2ȸ ´ëÇѺñ¸¸ÇÐȸ È£³²Áöȸ Çмú´ëȸ : 2024-06-01 0 80 2024-04-29
20557 ÀÎõ 2024³â ±èÆ÷½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-01 0 54 2024-04-29
20556 ¼­¿ï 2024 ´ëÇÑ¿ì¿ïÇൿ½Å°æÇבּ¸È¸ Ãá°èÇмú´ëȸ : 2024-06-01 0 50 2024-04-29
20555 ¼­¿ï ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ Á¦38Â÷ Ãá°èÅëÇÕÇмú´ëȸ ¹× ¿¬¼ö±³À° (2ÀÏÂ÷) : 2024-06-01 0 41 2024-04-29
20554 ¼­¿ï Á¦ 14Â÷ ´ëÇѸð¹ßÀ̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-01 0 52 2024-04-29
20553 ¼­¿ï 2024³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 62 2024-04-29
20552 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦297Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-31 0 74 2024-04-29
20551 ¼­¿ï (¿Â¶óÀÎ) 2024 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 98 2024-04-29
20550 ºÎ»ê Á¦ 169Â÷ ºÎ»êÁö¹æ³²¼º°úÇÐȸ Çмú´ëȸ : 2024-05-31 0 53 2024-04-29
20549 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦26ȸ ¿¬¼ö°­Á : 2024-05-30 0 51 2024-04-29
20548 °­¿ø 2024³â ¿øÁÖ½ÃÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß : 2024-05-28 0 61 2024-04-29
20547 °æ±â Á¦4ȸ ´ëÇÑ¿Ü°úÇÐȸ ¿Ü°ú³»½Ã°æ ¿¬¼ö°­Á : 2024-05-26 0 68 2024-04-29
20546 ¼­¿ï ´ëÇѺñ´¢ÃÊÀ½ÆÄÇÐȸ Á¦17Â÷ Çмú´ëȸ : 2024-05-26 0 42 2024-04-29
20545 °æºÏ 2024³âµµ °æ»óºÏµµÀÇ»çȸ Á¾ÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-26 0 75 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷